Browsing by Keyword : Angiotensin Receptor Antagonists
Showing results 7 to 14 of 14
| Pub Year | | Title | Author(s) |
| 2021 | | Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19 | 김대중 |
| 2018 | | Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study | 박인휘 |
| 2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
| 2016 | | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension | 강대용 |
| 2014 | | Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? | 김흥수, 박래웅, 박인휘, 신규태, 신승수 |
| 1999 | | Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. | 이수환, 정이숙 |
| 2014 | | SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multi-center, retrospective, observational study | 신준한 |
| 2015 | | The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. | 김흥수, 박래웅, 박인휘, 신규태, 신승수 |
1
